| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Neoplasms | Phase 1 | ClinicalTrials |
| Myelodysplastic Syndromes; Preleukemia; Syndrome | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Fibromatosis, Aggressive | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Transitional Cell | Phase 2 | ClinicalTrials |
| Stomach Neoplasms | Phase 1 | ClinicalTrials |
| Adenocarcinoma; Esophageal Neoplasms; Stomach Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Multiple Myeloma; Neoplasms, Plasma Cell | Phase 1 | ClinicalTrials |
| Adenocarcinoma | Phase 1/Phase 2 | ClinicalTrials |
CONTENTS